What are the diagnostic criteria for iron deficiency anemia (IDA) in an adult patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 10, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnostic Criteria for Iron Deficiency Anemia (IDA)

Iron deficiency anemia is diagnosed when hemoglobin falls below 13 g/dL in men or below 12 g/dL in non-pregnant women, combined with laboratory evidence of iron deficiency—most reliably a serum ferritin <15 μg/L (highly specific) or <30-45 μg/L in clinical practice. 1, 2

Hemoglobin Thresholds for Anemia

The World Health Organization defines anemia as: 1, 2

  • Men: Hemoglobin <13.0 g/dL (130 g/L)
  • Non-pregnant women: Hemoglobin <12.0 g/dL (120 g/L)
  • Pregnant women: Hemoglobin <11.0 g/dL (110 g/L)

While these are standard thresholds, it is reasonable to use your local laboratory's lower limit of normal range to define anemia, as normal ranges vary between populations. 1 However, men with hemoglobin <12 g/dL and postmenopausal women with hemoglobin <10 g/dL should be investigated more urgently, as lower levels suggest more serious underlying disease. 1

Serum Ferritin: The Primary Diagnostic Test

Serum ferritin is the single most specific and powerful test for diagnosing iron deficiency. 1, 2, 3

Ferritin Interpretation Algorithm:

  • Ferritin <15 μg/L: Highly specific for iron deficiency (specificity 0.99), indicating complete absence of iron stores 1, 2
  • Ferritin <30 μg/L: Generally indicates low body iron stores in patients without inflammation 2, 3
  • Ferritin <45 μg/L: Optimal clinical cutoff providing good specificity (0.92), especially when inflammatory processes are suspected 1, 2
  • Ferritin <100 μg/L: May still indicate iron deficiency in the presence of inflammatory conditions 4
  • Ferritin >150 μg/L: Makes absolute iron deficiency unlikely, even with inflammation 1, 2

Critical caveat: Ferritin is an acute phase reactant and rises with inflammation, infection, liver disease, and malignancy. 1 In patients with chronic inflammatory conditions (heart failure, chronic kidney disease, inflammatory bowel disease), standard ferritin cutoffs become unreliable and higher thresholds must be used. 1, 2

Transferrin Saturation: Supporting Evidence

Transferrin saturation <20% supports the diagnosis of iron deficiency when ferritin is equivocal. 4, 3 This is calculated as: (serum iron/total iron binding capacity) × 100. 3

In patients without inflammation, a ferritin level of 46-99 ng/mL plus transferrin saturation <20% is diagnostic of iron deficiency. 5

Red Blood Cell Indices

Mean corpuscular hemoglobin (MCH) is more reliable than mean corpuscular volume (MCV) for diagnosing iron deficiency, as it is less dependent on storage conditions and equipment, and is reduced in both absolute and functional iron deficiency. 2

Typical findings include: 4

  • Microcytosis: MCV <80 fL
  • Hypochromia: Reduced MCH
  • Elevated red cell distribution width (RDW), particularly in combined deficiencies

Additional Laboratory Markers

When standard tests are equivocal or inflammation is present: 1, 2

  • Total iron binding capacity (TIBC): Raised in iron deficiency (>370 μg/dL)
  • Soluble transferrin receptor (sTfR): Good marker in healthy subjects, but elevated with increased erythropoietic drive (hemolytic anemias, thalassemias)
  • [sTfR/log₁₀ ferritin] ratio: May provide superior discrimination, particularly in chronic disease
  • Red cell zinc protoporphyrin: Raised in iron deficiency
  • Reticulocyte hemoglobin content: Provides early indication of functional iron deficiency

Therapeutic Trial as Diagnostic Tool

A hemoglobin rise ≥10 g/L within 2 weeks of iron therapy is highly suggestive of absolute iron deficiency, even when iron study results are equivocal. 2, 4 This represents a practical diagnostic approach when laboratory findings are borderline or confounded by inflammation.

Clinical Context: Who to Test

Testing for iron deficiency is indicated for: 3

  • Patients with anemia of any degree
  • Symptoms of iron deficiency (fatigue, pica, restless legs syndrome, dyspnea, exercise intolerance)
  • Risk factors: heavy menstrual bleeding, pregnancy, inflammatory bowel disease, chronic kidney disease, heart failure, gastrointestinal bleeding, use of NSAIDs, post-bariatric surgery

In premenopausal women with non-anemic iron deficiency (low ferritin but normal hemoglobin), gastrointestinal investigation is generally not warranted unless there are GI symptoms or family history of GI pathology, as menstrual blood loss is the likely cause. 1 However, the threshold for investigation should be low in men, postmenopausal women, and those with GI symptoms. 1

Mandatory Screening Tests at Presentation

Once IDA is confirmed, initial investigation should include: 1, 4

  • Urinalysis or urine microscopy to exclude renal tract blood loss
  • Coeliac disease screening (tissue transglutaminase antibody), as it is found in 3-5% of IDA cases
  • Bidirectional endoscopy (gastroscopy and colonoscopy) in men and postmenopausal women, as gastrointestinal blood loss is the most common cause in these populations

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Iron Deficiency Diagnosis and Reference Ranges

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Diagnostic Approach to Iron Deficiency Anemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Iron Deficiency Anemia: Evaluation and Management.

American family physician, 2025

Related Questions

What are the diagnostic criteria for iron deficiency anemia in an adult patient?
What is the recommended assessment and treatment approach for a patient diagnosed with iron deficiency anemia?
How to manage iron supplementation in a patient with chronic iron deficiency anemia and elevated ferritin level?
What is the appropriate management for a post-menopausal woman with laboratory results indicating iron deficiency anemia, given her age and risk factors for gastrointestinal malignancy?
What is the appropriate assessment and management approach for a patient with suspected iron deficiency anemia, particularly in relation to ferritin levels and oral iron supplementation with ferrous sulfate (iron(II) sulfate)?
What is the likelihood of a patient with a history of gastrointestinal issues experiencing side effects when taking 2.5 mg of Zepbound (generic name)?
What is the most appropriate next investigation for a young boy with rectal prolapse, constipation, bulky and foul-smelling stools, failure to thrive, and recurrent pneumonia, with a positive sweat chloride test?
What is the appropriate initial oxygen supplementation flow rate for a patient with acute exacerbation of Chronic Obstructive Pulmonary Disease (COPD)?
What is the preferred initial treatment for a patient with anxiety, comparing Buspar (buspirone) to hydroxyzine, considering potential side effects and medical history, including substance abuse and impaired liver or kidney function?
Does meropenem (carbapenem antibiotic) cover Methicillin-resistant Staphylococcus aureus (MRSA) infections?
What medication should be added to a patient with dyslipidemia, normal cholesterol levels, and mildly elevated triglycerides, who is already taking a high-dose statin, to decrease cardiovascular risk?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.